WallStreetZenWallStreetZen

NYSE: EVMN
Evommune Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Evommune earnings were N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest EVMN earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EVMN reported annual earnings of -$68.3M, with 100.6% growth.

EVMN earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

EVMN Return on Equity

Insufficient data to display

EVMN undefined

Insufficient data to display

Be the first to know when EVMN announces earnings.

EVMN undefined

Current Company
0%
Current Industry
6.4%

EVMN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPGN/A-$161.45MN/A-$2.02
AARDN/AN/AN/AN/A
ABUS-$53.13M-$54.25MN/A-$0.29
ABVC-$3.58M-$4.12MN/A-$0.20
ABCL-$170.12M-$171.68MN/A-$0.57
View Top Biotech Stocks

Evommune Earnings Reports & History FAQ

What was EVMN's earnings growth in the past year?

As of Evommune's earnings date in Q4 2025, Evommune's earnings has grown year over year. EVMN earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Evommune stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.